YKH Stock Chart & Stats
€13.90
-€0.10(-0.58%)
At close: 4:00 PM EST
€13.90
-€0.10(-0.58%)
Day’s Range― - ―
52-Week Range€12.70 - €17.10
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€4.46B
Enterprise Value€740.66K
Total Cash (Recent Filing)€231.46B
Total Debt (Recent Filing)€114.10B
Price to Earnings (P/E)18.7
Beta0.12
Next Earnings
Nov 17, 2026EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)150.76
Shares Outstanding302,753,720
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio110.66
Price to Book (P/B)1.29
Price to Sales (P/S)1.60
P/FCF Ratio-59.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.9
Revenue Forecast (FY)€2.80B
Bulls Say, Bears Say
Bulls Say
Balance Sheet HealthConsistently low debt-to-equity and an expanding equity base give Yakult durable financial flexibility. This conservatively financed balance sheet supports investment in distribution, weathering demand shocks, and maintaining strategic programs or dividends without forcing immediate external financing.
Strong Gross MarginsSustained gross margins near 59–60% indicate structural product-level pricing power and cost advantage in core probiotics and dairy production. High gross margins provide a cushion against input-cost volatility and support long-term operating profitability even if revenue growth stalls.
Direct-to-Consumer DistributionThe Yakult Lady home-delivery network creates recurring, high-frequency demand and a customer loyalty moat for short-shelf-life beverages. This direct channel reduces reliance on intermediaries, stabilizes volumes, and boosts predictability of sales and marketing ROI over the medium term.
Bears Say
Operating Margin DropA drop in EBIT margin from ~16% to ~9% represents a material deterioration in operating efficiency or pricing power. If sustained, lower operating margins will compress returns on equity, reduce retained earnings for reinvestment, and weaken the firm's capacity to absorb cost shocks.
Negative Free Cash FlowA swing to negative free cash flow (~-13.1B) signals weaker cash conversion and higher cash outflows (capex or working capital). Persistent negative FCF would limit flexibility for capex, dividends, or buybacks and could force reliance on external financing despite low leverage.
Revenue ContractionA multi-percent decline in revenue growth indicates demand headwinds or execution challenges across markets. Sustained top-line contraction undermines economies of scale, pressures fixed-cost absorption, and makes margin recovery and long-term profitability improvements harder to achieve.
Yakult Honsha Co News
YKH FAQ
What was Yakult Honsha Co Ltd’s price range in the past 12 months?
Yakult Honsha Co Ltd lowest stock price was €12.70 and its highest was €17.10 in the past 12 months.
What is Yakult Honsha Co Ltd’s market cap?
Yakult Honsha Co Ltd’s market cap is €4.46B.
When is Yakult Honsha Co Ltd’s upcoming earnings report date?
Yakult Honsha Co Ltd’s upcoming earnings report date is Nov 17, 2026 which is in 106 days.
How were Yakult Honsha Co Ltd’s earnings last quarter?
Yakult Honsha Co Ltd released its earnings results on Jul 31, 2026. The company reported €0.259 earnings per share for the quarter, beating the consensus estimate of €0.14 by €0.119.
Is Yakult Honsha Co Ltd overvalued?
According to Wall Street analysts Yakult Honsha Co Ltd’s price is currently Overvalued.
Does Yakult Honsha Co Ltd pay dividends?
Yakult Honsha Co Ltd does not currently pay dividends.
What is Yakult Honsha Co Ltd’s EPS estimate?
Yakult Honsha Co Ltd’s EPS estimate is 0.26.
How many shares outstanding does Yakult Honsha Co Ltd have?
Yakult Honsha Co Ltd has 302,753,720 shares outstanding.
What happened to Yakult Honsha Co Ltd’s price movement after its last earnings report?
Yakult Honsha Co Ltd reported an EPS of €0.259 in its last earnings report, beating expectations of €0.14. Following the earnings report the stock price went down -2.564%.
Which hedge fund is a major shareholder of Yakult Honsha Co Ltd?
Currently, no hedge funds are holding shares in DE:YKH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yakult Honsha Co Ltd
Yakult Honsha Co.,Ltd. is a diversified Japanese enterprise engaged in the manufacturing and sale of a broad array of products, including food and beverages, cosmetics, and pharmaceuticals. The company's operations are segmented geographically for its Food and Beverages division, covering Japan, the Americas, Asia and Oceania, and Europe, alongside dedicated Pharmaceutical and "Others" segments. Its extensive food and beverage offerings feature popular items such as fermented milk beverages, various juices, and noodle products, which are distributed through both a home delivery service and traditional retail channels. In the pharmaceutical sector, Yakult Honsha provides specific medications like the antineoplastic drug Elplat, along with a suite of generic anti-cancer treatments, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. Furthermore, the company maintains a presence in the cosmetics industry and is notably the owner of the professional baseball team, the Tokyo Yakult Swallows. Founded in 1935, Yakult Honsha Co.,Ltd. is headquartered in Tokyo, Japan.
YKH Company Deck
YKH Earnings Call
Q4 2026
0:00 / 0:00
Technical Analysis
ITO EN
―
Meiji Holdings Co
―
Suntory Beverage & Food
―
Morinaga Milk Industry Co., Ltd.
―
DyDo Group Holdings, Inc.
―